Article info
PDFCorrespondence
More evidences on which biologic and which pathway is key in severe-critical COVID-19 pneumonia
- Correspondence to Professor Gianfranco Ferraccioli, Department of Rheumatology, Policlinico Universitario Agostino Gemelli, Universita' Cattolica del Sacro Cuore, Roma 00168, Lazio, Italy; gianfranco.ferraccioli{at}unicatt.it
Citation
More evidences on which biologic and which pathway is key in severe-critical COVID-19 pneumonia
Publication history
- Received July 9, 2020
- Accepted July 10, 2020
- First published July 31, 2020.
Online issue publication
October 18, 2023
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for personal use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage